Asset Management One Co., Ltd. Alnylam Pharmaceuticals, Inc. Transaction History

Asset Management One Co., Ltd.

  • $31.2 Billion
  • Q2 2025

A detailed history of Asset Management One Co., Ltd. transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Asset Management One Co., Ltd. holds 69,310 shares of ALNY stock, worth $30.4 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
69,310
Previous 68,457 1.25%
Holding current value
$30.4 Million
Previous $18.5 Million 22.27%
% of portfolio
0.07%
Previous 0.07%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Jul 31, 2025
BUY
$224.32 - $326.09 $191,344 - $278,154
853 Added 1.25%
69,310 $22.6 Million
Q1 2025

Apr 23, 2025
BUY
$233.07 - $290.7 $721,118 - $899,425
3,094 Added 4.73%
68,457 $18.5 Million
Q4 2024

Jan 30, 2025
SELL
$232.27 - $300.43 $601,579 - $778,113
-2,590 Reduced 3.81%
65,363 $15.4 Million
Q3 2024

Oct 30, 2024
BUY
$233.81 - $287.01 $527,709 - $647,781
2,257 Added 3.44%
67,953 $18.7 Million
Q2 2024

Jul 18, 2024
SELL
$143.31 - $247.0 $318,578 - $549,081
-2,223 Reduced 3.27%
65,696 $16 Million
Q1 2024

May 02, 2024
SELL
$146.51 - $198.2 $207,311 - $280,453
-1,415 Reduced 2.04%
67,919 $10.2 Million
Q4 2023

Jan 24, 2024
BUY
$151.41 - $196.57 $3.07 Million - $3.98 Million
20,268 Added 41.31%
69,334 $13.3 Million
Q3 2023

Oct 19, 2023
SELL
$170.77 - $211.65 $57,891 - $71,749
-339 Reduced 0.69%
49,066 $8.69 Million
Q2 2023

Jul 31, 2023
BUY
$185.01 - $212.05 $190,005 - $217,775
1,027 Added 2.12%
49,405 $9.38 Million
Q1 2023

Apr 25, 2023
BUY
$182.66 - $235.53 $99,732 - $128,599
546 Added 1.14%
48,378 $9.69 Million
Q4 2022

Feb 06, 2023
SELL
$185.53 - $241.31 $190,168 - $247,342
-1,025 Reduced 2.1%
47,832 $11.4 Million
Q3 2022

Nov 04, 2022
SELL
$138.54 - $232.0 $361,173 - $604,824
-2,607 Reduced 5.07%
48,857 $9.78 Million
Q2 2022

Jul 29, 2022
BUY
$120.42 - $169.29 $148,237 - $208,395
1,231 Added 2.45%
51,464 $7.51 Million
Q1 2022

May 13, 2022
SELL
$127.18 - $173.91 $264,407 - $361,558
-2,079 Reduced 3.97%
50,233 $8.2 Million
Q4 2021

Feb 09, 2022
SELL
$159.56 - $209.29 $53,612 - $70,321
-336 Reduced 0.64%
52,312 $8.9 Million
Q3 2021

Nov 02, 2021
SELL
$169.75 - $207.73 $50,585 - $61,903
-298 Reduced 0.56%
52,648 $9.94 Million
Q2 2021

Aug 03, 2021
SELL
$128.63 - $176.89 $237,708 - $326,892
-1,848 Reduced 3.37%
52,946 $8.98 Million
Q1 2021

May 14, 2021
SELL
$126.83 - $175.69 $6,087 - $8,433
-48 Reduced 0.09%
54,794 $7.74 Million
Q4 2020

Feb 12, 2021
SELL
$122.97 - $147.0 $94,072 - $112,455
-765 Reduced 1.38%
54,842 $7.16 Million
Q3 2020

Nov 13, 2020
SELL
$121.19 - $165.49 $323,456 - $441,692
-2,669 Reduced 4.58%
55,607 $8.1 Million
Q2 2020

Aug 14, 2020
SELL
$104.21 - $156.44 $1,667 - $2,503
-16 Reduced 0.03%
58,276 $8.63 Million
Q1 2020

May 14, 2020
SELL
$93.12 - $133.99 $134,092 - $192,945
-1,440 Reduced 2.41%
58,292 $6.34 Million
Q4 2019

Feb 14, 2020
BUY
$74.51 - $124.23 $134,788 - $224,732
1,809 Added 3.12%
59,732 $6.88 Million
Q3 2019

Nov 14, 2019
BUY
$70.9 - $87.82 $623,849 - $772,728
8,799 Added 17.91%
57,923 $4.66 Million
Q2 2019

Aug 14, 2019
SELL
$65.86 - $92.79 $37,145 - $52,333
-564 Reduced 1.14%
49,124 $3.56 Million
Q1 2019

May 15, 2019
SELL
$72.76 - $93.45 $6.56 Million - $8.43 Million
-90,193 Reduced 64.48%
49,688 $4.64 Million
Q4 2018

Feb 13, 2019
SELL
$62.67 - $88.33 $5,577 - $7,861
-89 Reduced 0.06%
139,881 $10.2 Million
Q3 2018

Nov 14, 2018
BUY
$87.52 - $122.67 $112,025 - $157,017
1,280 Added 0.92%
139,970 $12.3 Million
Q2 2018

Aug 14, 2018
BUY
$88.31 - $107.8 $252,389 - $308,092
2,858 Added 2.1%
138,690 $13.7 Million
Q1 2018

May 14, 2018
BUY
$115.92 - $148.54 $14,142 - $18,121
122 Added 0.09%
135,832 $16.2 Million
Q4 2017

Feb 14, 2018
BUY
$114.49 - $139.98 $15.5 Million - $19 Million
135,710
135,710 $17.3 Million

Others Institutions Holding ALNY

# of Institutions
746
Shares Held
110M
Call Options Held
966K
Put Options Held
841K
View Full List

About ALNYLAM PHARMACEUTICALS, INC.

ALNY Quotes by TradingView
  • Ticker ALNY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 123,028,000
  • Market Cap $54B
  • Description
  • Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...
More about ALNY
Track This Portfolio

Track Asset Management One Co., Ltd. Portfolio

Follow Asset Management One Co., Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Asset Management One Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Asset Management One Co., Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email